new weight loss drug retatrutide (“reta”) is an experimental weight-loss currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Color:Indigo Purple Health Aid Semaglutide alleviates osteoarthritis independent

new weight loss drug retatrutide (“reta”) is an experimental weight-loss currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Color:Indigo Purple Health Aid Semaglutide alleviates osteoarthritis independent

Semaglutide alleviates osteoarthritis independent of weight loss via GLP-1R–mediated activation of autophagy through AKT/mTOR inhibition - ScienceDirect

The exact threshold varies depending on the medication and is determined in consultation with a healthcare provider

Health Aid

Color:Indigo Purple

This action marks the drug as the first-ever generic glucagon-like peptide-1 (GLP-1) receptor agonist indicated for adults with obesity or overweight who also have a weight-related medical problem and pediatric patients aged 12 to 17 years with a weight greater than 60 kg and obesity specifically to aid weight loss and keep the weight off